Serveur d'exploration Stress et Covid - Exploration (Accueil)

Index « AbsEn.i » - entrée « drugs »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
drugmakers < drugs < drugsinhibiting  Facettes :

List of bibliographic references indexed by drugs

Number of relevant bibliographic references: 128.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000015 (2020) Nello Martini ; Carlo Piccinni ; Antonella Pedrini ; Aldo Maggioni[CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project.]
000071 (2020) Lei Li [République populaire de Chine] ; Ranran Li [République populaire de Chine] ; Zhixiong Wu [République populaire de Chine] ; Xianghong Yang ; Mingyan Zhao [République populaire de Chine] ; Jiao Liu [République populaire de Chine] ; Dechang Chen [République populaire de Chine]Therapeutic strategies for critically ill patients with COVID-19
000087 (2020) Yi-Chi Wu [République populaire de Chine] ; Ching-Sung Chen [République populaire de Chine] ; Yu-Jiun Chan [République populaire de Chine]The outbreak of COVID-19: An overview
000110 (2020) Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie]The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
000181 (2020) Gianluca Trifir [Italie] ; Salvatore Crisafulli [Italie] ; Giuseppe And [Italie] ; Giorgio Racagni [Italie] ; Filippo Drago [Italie]Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
000185 (2020) Shu-Ren Li ; Zi-Jian Tang [République populaire de Chine] ; Zai-Han Li ; Xuan Liu [République populaire de Chine]Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV
000276 (2020) Rong Li [République populaire de Chine] ; Tailang Yin [République populaire de Chine] ; Fang Fang [République populaire de Chine] ; Qin Li [République populaire de Chine] ; Jiao Chen [République populaire de Chine] ; Yixin Wang [États-Unis] ; Yongxiu Hao [République populaire de Chine] ; Gengxiang Wu [République populaire de Chine] ; Peng Duan [République populaire de Chine] ; Yuanyuan Wang [République populaire de Chine] ; Dan Cheng [République populaire de Chine] ; Qi Zhou [République populaire de Chine] ; Mohammad Ishraq Zafar [République populaire de Chine] ; Chengliang Xiong [République populaire de Chine] ; Honggang Li [République populaire de Chine] ; Jing Yang [République populaire de Chine] ; Jie Qiao [République populaire de Chine]Potential risks of SARS-Cov-2 infection on reproductive health
000314 (2020) Samad Ghaffari [Iran] ; Neda Roshanravan [Iran] ; Helda Tutunchi [Iran] ; Alireza Ostadrahimi [Iran] ; Mahboub Pouraghaei [Iran] ; Behnam Kafil [Iran]Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19
000333 (2020) Yadi Zhou [États-Unis] ; Yuan Hou [États-Unis] ; Jiayu Shen [États-Unis] ; Yin Huang [États-Unis] ; William Martin [États-Unis] ; Feixiong Cheng [États-Unis]Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
000343 (2020) Yawen Zeng [République populaire de Chine] ; Xiaoying Pu [République populaire de Chine] ; Juan Du [République populaire de Chine] ; Xiaomeng Yang [République populaire de Chine] ; Xia Li [République populaire de Chine] ; Md. Siddikun Nabi Mandal [Bangladesh] ; Tao Yang [République populaire de Chine] ; Jiazhen Yang [République populaire de Chine]Molecular Mechanism of Functional Ingredients in Barley to Combat Human Chronic Diseases
000386 (2020) Jeanne-Marie Lawrence [États-Unis] ; Niamat Ullah Ibne Hossain [États-Unis] ; Raed Jaradat [États-Unis] ; Michael Hamilton [États-Unis]Leveraging a Bayesian Network approach to model and analyze supplier vulnerability to severe weather risk: A case study of the U.S. pharmaceutical supply chain following Hurricane Maria
000405 (2020) Ahmed S. Abouhashem [États-Unis] ; Kanhaiya Singh [États-Unis] ; Hassan Me Azzazy [États-Unis] ; Chandan K. Sen [États-Unis]Is Low Alveolar Type II Cell SOD3 in the Lungs of Elderly Linked to the Observed Severity of COVID-19?
000418 (2020) Steven LehrerInhaled biguanides and mTOR inhibition for influenza and coronavirus (Review)
000462 (2020) Antoinette Maassenvandenbrink ; Tessa De Vries ; A. H. Jan DanserHeadache medication and the COVID-19 pandemic
000525 (2020) Kai Liu [République populaire de Chine] ; Ying Chen [République populaire de Chine] ; Duozhi Wu [République populaire de Chine] ; Ruzheng Lin [République populaire de Chine] ; Zaisheng Wang [République populaire de Chine] ; Liqing Pan [République populaire de Chine]Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19
000542 (2020) Noura M. Seleem [Égypte] ; Hemat K. Abd El Latif [Égypte] ; Moataz A. Shaldam [Égypte] ; Amira El-Ganiny [Égypte]Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections
000645 (2020) Elena Carboni [Italie] ; Anna Rosa Carta [Italie] ; Ezio Carboni [Italie]Can pioglitazone be potentially useful therapeutically in treating patients with covid-19?
000667 (2020) Imran Ali [Arabie saoudite, Inde] ; Omar M. L. Alharbi [Arabie saoudite]COVID-19: Disease, management, treatment, and social impact
000740 (2020) Chandramohan Kiruthiga [Inde] ; Kasi Pandima Devi [Inde] ; Seyed Mohammad Nabavi [Iran] ; Anupam Bishayee [États-Unis]Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma.
000742 (2020) Beth Russell [Royaume-Uni] ; Charlotte Moss [Royaume-Uni] ; Gincy George [Royaume-Uni] ; Aida Santaolalla [Royaume-Uni] ; Andrew Cope [Royaume-Uni] ; Sophie Papa [Royaume-Uni] ; Mieke Van Hemelrijck [Royaume-Uni]Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
000756 (2020) Elena V. Proskurnina [Russie] ; Dmitry Yu Izmailov [Russie] ; Madina M. Sozarukova [Russie] ; Tatiana A. Zhuravleva [Russie] ; Irina A. Leneva [Russie] ; Artem A. Poromov [Russie]Antioxidant Potential of Antiviral Drug Umifenovir.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "drugs" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "drugs" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    drugs
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021